16th International Hemophilia Congress in Turkey
A scientific symposium on the prevention and eradication of inhibitors in patients affected by Hemophilia A
Kedrion Biopharma Announces Completion of Enrollment for CARES10
A Phase 3, Multi-Center Study to Assess a 10% Ig in Adults with Primary Immunodeficiency Disease
First Annual International Symposium for the Global Eradication of Rh Disease ends a year of celebrations
The event, supported by Kedrion among others, was held on November 1st at Columbia University in NY
Kedrion renews its commitment to PID patients at ESID 2018
18th edition of the Biennial Meeting of the European Society for Immunodeficiencies helds in Lisbon (Oct. 24 to 27)
50 years of Anti-D celebrated at World Congress of Gynecology and Obstetrics in Rio De Janeiro
Kedrion supports educational symposium to help Rh disease awareness and eradication
EIGHT, the global educational initiative on Hemophilia A and its treatment
Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October
Kedrion Biopharma participates in the Mother and Child Conference in Moscow
A 50 years of Anti-D dedicated programme presented at the main Russian congress of Gynecology and Obstetrics
Kedrion joins Rhesus Solution Initiative (RSI) symposium in Lagos
Nigeria to advocate for Rh Disease universal eradication
Kedrion Joins Annual PNS Conference on Neurology
The company took part in the event with a booth and a delegation of 40 int’l guests
Kedrion Biopharma celebrates Primary Immunodeficiency Week
The company stands alongside PI patients associations around the globe